APA (7th ed.) Citation

Pillet, S., Couillard, J., Trépanier, S., Poulin, J., Yassine-Diab, B., Guy, B., . . . Landry, N. (2019). Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults. PloS one, 14(6), e0216533. https://doi.org/10.1371/journal.pone.0216533

Chicago Style (17th ed.) Citation

Pillet, Stéphane, Julie Couillard, Sonia Trépanier, Jean-François Poulin, Bader Yassine-Diab, Bruno Guy, Brian J. Ward, and Nathalie Landry. "Immunogenicity and Safety of a Quadrivalent Plant-derived Virus like Particle Influenza Vaccine Candidate—Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults." PloS One 14, no. 6 (2019): e0216533. https://doi.org/10.1371/journal.pone.0216533.

MLA (9th ed.) Citation

Pillet, Stéphane, et al. "Immunogenicity and Safety of a Quadrivalent Plant-derived Virus like Particle Influenza Vaccine Candidate—Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults." PloS One, vol. 14, no. 6, 2019, p. e0216533, https://doi.org/10.1371/journal.pone.0216533.